What’s the current market cap for Select Medical stock?

Select Medical (SEM) has a market cap of $2B as of May 27, 2026.

What is the P/E ratio for Select Medical stock?

The price to earnings (P/E) ratio for Select Medical (SEM) stock is 15.39 as of May 27, 2026.

Does Select Medical stock pay dividends?

Yes, the Select Medical (SEM) stock pays dividends to shareholders. As of May 27, 2026, the dividend rate is $0.25 and the yield is 1.51%. Select Medical has a payout ratio of 23.31% on a trailing twelve-month basis.

When is the next Select Medical dividend payment date?

The next Select Medical (SEM) dividend payment is scheduled for May 28, 2026.

What is the beta indicator for Select Medical?

Select Medical (SEM) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Select Medical stock | $SEM Share Price

About Select Medical

Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.

Ticker

$SEM

Sector

Health

Primary listing

NYSE

Employees

38,050

Headquarters

Mechanicsburg, United States

Website

www.selectmedical.com

Select Medical Metrics

BasicAdvanced

$2bn

15.39

$1.07

0.80

$0.25

1.51%

What the Analysts think about Select Medical

Analyst ratings (Buy, Hold, Sell) for Select Medical stock.

Bulls say / Bears say

Revenue rose 5.0% year-over-year to $1.4215 billion, topping the IBES consensus of $1.411 billion and demonstrating resilience amid market uncertainty (Reuters(sahmcapital.com))

The pending $3.9 billion take-private transaction at $16.50 per share represents an 18% premium over the November 24, 2025 closing price, securing a material value realization for shareholders (Reuters(in.investing.com))

The $16.50 offer equates to an 8.7× multiple on management’s 2026 adjusted EBITDA estimate—below peer valuations—suggesting the company may be undervalued and offering potential upside if the deal terms change (Reuters(uk.investing.com))

Q1 net income declined 14.7% year-over-year to $63.8 million, reflecting significant margin pressure in its post-acute care operations (Reuters(sahmcapital.com); Press Release(selectmedical.com))

Adjusted EBITDA fell 6.5% to $141.6 million from $151.4 million a year earlier, underscoring cost headwinds and compressing profitability in its core hospital and outpatient segments (Press Release(selectmedical.com))

Adjusted earnings per share dropped to $0.36 from $0.44 in the prior-year quarter, pointing to declining operational leverage and weaker earnings power (Press Release(selectmedical.com))

Data summarised monthly by Lightyear AI. Last updated on 21 May 2026.

Select Medical Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

Select Medical Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Select Medical News

AllArticlesVideos

SELECT MEDICAL HOLDINGS CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Select Medical Holdings Corporation's Directors and Officers for Breach of Fiduciary Duties - SEM

Newsfile Corp·6 days ago

SEM PRIVATIZATION ALERT: Kaskela Law Firm Announces Investigation of Select Medical Holdings Privatization Transaction and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options

Newsfile Corp·2 weeks ago

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Select Medical Holdings Shareholder Buyout and Encourages Investors to Contact the Firm – SEM

Business Wire·3 weeks ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.